HYPD — HYPERION DEFI, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1682639 ·
Last close
$3.91
Market Cap
$60.84M
52W High
$11.89
52W Low
$2.34
ADV30
663,277
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 357,693 | 357,693 | -2,709,548 | 30,950,963 | 113,138,918 | 9,637,216 | 11,204,147 |
| Mar 2026 | 244,271 | 244,271 | -5,040,608 | 8,840,550 | 70,065,963 | 7,380,922 | 11,570,999 |
| Dec 2025 | 496,229 | 192,987 | -4,931,840 | -39,765,565 | 51,764,256 | 6,443,467 | 10,703,749 |
| Sep 2025 | 302,506 | 302,506 | -2,665,479 | 6,625,582 | 82,789,907 | 8,223,180 | 12,034,875 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-14,523,980
Investing CF
$-73,426,874
Financing CF
$91,396,810
CapEx
$-27,903,916
Dividends Paid
$-795,000
Buybacks
—
EPS Diluted TTM
$-3.78
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-231,783,877
Inventory
$0
Receivables
$351,064
ST Investments
—
EBIT TTM
$-31,788,194
Pretax Income TTM
$-32,990,352
Interest Exp TTM
$1,202,158
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,400,699
EBITDA
—
Free Cash Flow
$-14,804,011
Enterprise Value
$53,507,852
Total Cash
$9,637,216
Total Debt
$8,911,919
Shares Out
15,539,434
Trailing EPS
$-3.86
Book Value
$6.66
ROE
9.6%
ROA
-11.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 813,455 | -18,981,294 | -45,314,435 | 51,764,256 | 10,703,749 | 41,060,507 | -14,770,174 |
| Dec 2024 | 57,336 | -37,530,328 | -49,818,433 | 3,667,759 | 16,763,711 | -13,095,952 | -30,120,981 |
| Dec 2023 | 3,787 | -25,406,446 | -27,261,096 | 28,779,374 | 19,780,280 | 8,999,094 | -23,836,539 |
| Dec 2022 | 0 | -26,911,515 | -28,011,157 | 31,036,413 | 13,801,848 | 17,234,565 | -25,105,482 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ZYBT | Zhengye Biotechnology Holding Ltd | $61.61M | $1.30 | — |
| TLPH | TALPHERA, INC. | $61.77M | $1.19 | — |
| XLO | Xilio Therapeutics, Inc. | $59.55M | $9.05 | — |
| RNTX | Rein Therapeutics, Inc. | $62.20M | $0.72 | — |
| ACET | Adicet Bio, Inc. | $59.45M | $6.35 | — |
News headlines (Yahoo Finance, 1h cache)
Trump's White House Endorsement 'Extremely Positive,' Says Hyperion DeFi CEO: Executive Explains Why HYPE Ownership Is 'Beneficial'
2026-09-11 02:30 · Yahoo
Hyperion DeFi Inc (HYPD) (Q2 2026) Earnings Call Highlights: Strategic Pivot and Treasury ...
2026-08-13 05:01 · Yahoo
Hyperion DeFi (HYPD) Q1 2026 Earnings Transcript
2026-05-14 18:21 · Yahoo
Hyperion DeFi, Inc. Q2 2026 Earnings Call Summary
2026-08-13 12:30 · Yahoo
Hyperion Profit More Than Triples to $31M, HYPE Treasury Reaches $133M
2026-08-13 00:01 · Yahoo
Hyperion Deploys 500,000 HYPE to Back Skew’s HIP-3 Market Push
2026-07-16 04:28 · Yahoo
Hyperion DeFi Taps Blockdaemon to Expand Hyperliquid Staking Infrastructure
2026-06-22 18:50 · Yahoo
Hyperion CEO Says HYPE Rally Still Undervalues Hyperliquid’s Ecosystem Shift
2026-06-18 23:11 · Yahoo
Hyperion DeFi, Inc. Q1 2026 Earnings Call Summary
2026-05-15 12:30 · Yahoo
Hyperion DeFi Inc (HYPD) Q1 2026 Earnings Call Highlights: Strong Growth Amidst Token Volatility
2026-05-14 23:03 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.